PD-1 antibody was approved as first-line treatment for locally recurrent or metastatic squamous cell anal carcinoma.

With two concurrent FDA approvals, Incyte’s PD-1 inhibitor Zynyz has redeemed itself in anal cancer four years after an ...

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

The latecomer PD-1 inhibitor – already approved for Merkel cell carcinoma – has become the first cancer immunotherapy for ...

Zynyz is the first and only FDA-approved first-line treatment for adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal.

The FDA approves INCY's Zynyz both as monotherapy and in combination with chemotherapy for treating advanced anal cancer.

Incyte Corp.’s Zynyz (retifanlimab-dlwr) has received another U.S. FDA approval and put some distance between it and a 2021 ...

When Queensland mum Kelly O'Donnell couldn't shake off the fatigue, she figured motherhood had simply taken its toll. But ...

Mornement told HuffPost that medium to large dogs are more likely to be “opportunistic crotch-sniffers,” meaning that they might take a sniff if their nose happens to be in the vicinity of a woman on ...

A healthy 39-year-old Manchester resident, who thought his constant bloating and diarrhoea were due to food intolerance, was diagnosed with bowel cancer, which had a 7 am tumour near his stomach. Rob ...

Own your power, dearest Cancer. As Ceres moves into Aries, you will possess a greater presence within your relationship and the lives of those around you. You will fervently desire to be your ...